The initial clinical assessments elicited stark awareness of a syndromic condition of varied causes (originally rheumatic heart disease, hypertension, and coronary disease) characterized by abysmal ...

The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...

A multi-institutional research team found that tricaprin, a natural supplement, improved long-term survival rates in patients with triglyceride deposit cardiomyovasculopathy, a new type of heart ...

The CORCINCH-HF study, which the Heart Hospital of New Mexico at Lovelace Medical Center is the first in the state to join, ...

Saint Francis is in the middle of a two-year double-blind clinical trail for a device that could potentially help people with congestive heart failure. When Gail Knox was diagnosed with a type of ...

Three months of CS1 therapy boosted quality of life, while symptoms tied to heart failure and clinical worsening and ...

There used to be no specific treatments for heart failure with preserved ejection fraction, but recent clinical trials show ...

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

A troubling reality lurks within the halls of hospitals and medical practices across the globe: women with heart disease consistently receive different treatment than men with the same condition.

WhiteSwell is a patient-focused company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits. A privately ...

WhiteSwell is a patient-focused company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits.

Daxor Corporation has announced a multicenter study published in the Journal of Cardiac Failure, revealing important findings about heart failure treatment using their Blood Volume Analysis (BVA ...